Healthcare

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

This research service offers a strategic perspective of the customer, product, technology and competitors that are influencing the global market for surgical robotics. The report is split into three major sections, each focusing on industry overview, competitive landscape, and voice of stakeholder analysis. The report also includes sections for tec...

19 Sep 2018  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022

Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics

Infographics

×

Key Issues Addressed

The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...

This report looks broadly at the role of reality technologies in healthcare, investigating the landscape for established and emerging products and vendors; top growth opportunities for major healthcare use cases; and the potential adoption trajectory and competitive dynamics impacting the market. Virtual reality refers to an interactive, immersive...

The healthcare expenditure in Australia in the previous financial year was AUD 170.4 billion, with 10.3% of the gross domestic product (GDP), thereby allowing the country’s healthcare spending to pass the 10% mark for the first time. Healthcare expenditure continues to rise; however, the rate of increase has been curbed in the last few years. At ...

The Asia-Pacific medical imaging industry is in the growth stage. Both established and new medical imaging manufacturers in the region are constantly focusing on innovating new products, while simultaneously looking at ways to reduce the cost incurred for placing their products. Using these manufacturers as partners or joint venture participants of...

04 Sep 2018  |  North America  |  Market Research

Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018

Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities

Infographics

×

Key Issues Addressed

The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally ...

24 Aug 2018  |  North America  |  Mega Trends

Artificial Intelligence Market—Key Application Areas for Growth in Healthcare IT, Forecast to 2022

Optimizing Quality and Efficiency of Healthcare Delivery with AI

Infographics

×

Key Issues Addressed

The study describes how AI technologies are paired with legacy healthcare IT systems to deal with the complexity & growth of medical data. Frost & Sullivan acknowledges that AI intuitively finds ways to convert these ever-expanding resources into actionable evidence for end users. In this study, Frost & Sullivan has forecast global revenue for prim...